MetLife Investment Management, LLC - MADRIGAL PHARMACEUTICALS INC ownership

MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 148 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of MADRIGAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,048,129
-36.8%
7,1770.0%0.01%
-33.3%
Q2 2023$1,657,887
+2.4%
7,177
+7.4%
0.01%0.0%
Q1 2023$1,618,782
-16.5%
6,6820.0%0.01%
-20.0%
Q4 2022$1,939,451
+346.6%
6,6820.0%0.02%
+275.0%
Q3 2022$434,263
-9.2%
6,6820.0%0.00%0.0%
Q2 2022$478,298
-27.0%
6,6820.0%0.00%0.0%
Q1 2022$655,638
+83.6%
6,682
+58.6%
0.00%
+33.3%
Q4 2021$357,094
+21.4%
4,214
+14.3%
0.00%0.0%
Q3 2021$294,186
-18.1%
3,6870.0%0.00%0.0%
Q2 2021$359,151
-16.7%
3,6870.0%0.00%
-25.0%
Q1 2021$431,268
+5.2%
3,6870.0%0.00%0.0%
Q4 2020$409,884
-6.4%
3,6870.0%0.00%
-20.0%
Q3 2020$437,758
+4.8%
3,6870.0%0.01%0.0%
Q2 2020$417,553
+69.6%
3,6870.0%0.01%
+66.7%
Q1 2020$246,144
-26.7%
3,6870.0%0.00%
-25.0%
Q4 2019$335,923
+5.7%
3,6870.0%0.00%0.0%
Q3 2019$317,893
-17.7%
3,6870.0%0.00%0.0%
Q2 2019$386,433
-1.2%
3,687
+18.1%
0.00%0.0%
Q1 2019$391,187
+11.1%
3,1230.0%0.00%0.0%
Q4 2018$352,025
-47.4%
3,1230.0%0.00%
-42.9%
Q3 2018$668,728
-11.4%
3,123
+15.6%
0.01%
-22.2%
Q2 2018$755,000
+205.7%
2,701
+27.7%
0.01%
+200.0%
Q1 2018$247,000
+27.3%
2,1150.0%0.00%
+50.0%
Q4 2017$194,0002,1150.00%
Other shareholders
MADRIGAL PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
HealthCor Management, L.P. 1,402,250$93,614,0004.00%
Parkman Healthcare Partners LLC 30,000$2,003,0000.93%
ARMISTICE CAPITAL, LLC 216,000$14,420,0000.89%
Avoro Capital Advisors LLC 349,000$23,299,0000.79%
Rock Springs Capital Management LP 250,000$16,690,0000.69%
Capital Impact Advisors, LLC 24,351$1,626,0000.68%
Baker Brothers Advisors 1,499,212$100,087,0000.62%
EWG Elevate Inc. 11,086$740,0000.56%
SHIKIAR ASSET MANAGEMENT INC 12,000$801,0000.54%
DAFNA Capital Management LLC 13,600$908,0000.38%
View complete list of MADRIGAL PHARMACEUTICALS INC shareholders